CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award See Remarks acquired 70,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 65,000 shares (grant or award)
- 4 Open-market sale See Remarks sold 5,980 shares at $1.55 ($9,269)
- 4 Open-market sale See Remarks sold 5,654 shares at $1.55 ($8,764)
- 4 Open-market sale President and CEO sold 8,705 shares at $1.54 ($13,406)
- 4 Open-market buy Director bought 397,964 shares at $1.68 ($668,580)
- 4 Conversion Director acquired 30,110 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 633 shares at $4.23 ($2,678)
- 4 Grant or award Chief R&D Officer acquired 200,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award General Counsel and Secretary acquired 200,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 21 · 403 filings